ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $202,998 | -63.4% | 9,995 | -62.7% | 0.00% | -100.0% |
| Q4 2022 | $554,307 | -60.2% | 26,804 | -39.2% | 0.00% | 0.0% |
| Q1 2022 | $1,391,000 | -89.7% | 44,087 | -86.8% | 0.00% | -90.9% |
| Q4 2021 | $13,477,000 | +100.3% | 332,994 | +72.6% | 0.01% | +83.3% |
| Q3 2021 | $6,729,000 | -31.0% | 192,963 | -45.6% | 0.01% | -25.0% |
| Q2 2021 | $9,746,000 | -37.9% | 354,946 | -36.5% | 0.01% | -46.7% |
| Q1 2021 | $15,706,000 | +6.3% | 559,309 | -1.8% | 0.02% | +15.4% |
| Q4 2020 | $14,780,000 | +40.4% | 569,333 | -7.3% | 0.01% | +18.2% |
| Q3 2020 | $10,525,000 | -4.5% | 614,037 | +37.9% | 0.01% | -15.4% |
| Q2 2020 | $11,016,000 | +3198.2% | 445,282 | +1245.3% | 0.01% | – |
| Q4 2019 | $334,000 | – | 33,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |